第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

第4章 市場調查手法

第5章 簡介

第6章 市場形勢

第7章 罹患率和得病率

第8章 各治療類型的市場區隔

第9章 各給藥途徑及劑型的市場區隔

第10章 產品研發線

第11章 地理區分

第12章 購買標準

第13章 市場成長因素

第14章 成長因素與其影響

第15章 市場課題

第16章 成長因素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 業者情勢

競爭模式

主要消息

市場佔有率分析

其他的供應商

第20章 主要供應商分析

AbbVie Inc.

AstraZeneca plc

Bayer AG

Pfizer Inc.

第21章 相關報告

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Product Code: IRTNTR3730

About Endometriosis

Endometriosis is a common female health condition where the endometrial
tissue, which is usually found inside the lining of the uterus, appear and
grows outside the uterine cavity. Endometriosis mostly occurs in the fallopian
tubes, ovaries, outer surface of the uterus, pelvic cavity, vagina, cervix,
and bladder. Endometriosis has rarely been reported in more distant parts of
the body such as the lungs, brain, and skin. The most common symptoms
associated with endometriosis are pelvic pain, dysmenorrhea, excessive
bleeding, and lower abdominal pain. Some of the uncommon symptoms of
endometriosis are rectal bleeding and hematuria. The detection of
endometriosis in women is difficult because of the common symptoms associated
with it. Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic
exam, and biopsy of the inner lining of the uterus. In a biopsy, the tissues
from the inner lining of the uterus of the patient are taken and tested using
the biomarkers for the presence of endometriosis. Endometriosis is an
incurable disease and relapses after the primary treatment. Currently, the
treatment options for endometriosis include the usage of hormone therapy and
analgesics to control the disease.

TechNavio's analysts forecast the Global Endometriosis market will grow at a
CAGR of 2.86 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global
Endometriosis market for the period 2013-2018. To calculate the market size,
the report considers the revenue generated from the sales of various drugs
used in the treatment of endometriosis that are available in the market.

TechNavio's report, the Global Endometriosis Market 2014-2018, has been
prepared based on an in-depth market analysis with inputs from industry
experts. The report covers the Americas, EMEA, and APAC regions; it also
covers the Global Endometriosis market landscape and its growth prospects in
the coming years. The report also includes a discussion of the key vendors
operating in this market.

Key Regions

Americas

EMEA

APAC

Key Vendors

Abbvie Inc.

AstraZeneca plc

Bayer AG

Pfizer Inc.

Other Prominent Vendors

Astellas Pharma Inc.

Abbvie Inc.

Repros Therapeutics Inc.

Sanofi SA

Takeda Pharmaceuticals Co. Ltd.

Key Market Driver

High Unmet Needs in the Market

For a full, detailed list, view our report.

Key Market Challenge

Patent Expiries of Approved Drugs

For a full, detailed list, view our report.

Key Market Trend

Expected Launch of High-cost Therapies

For a full, detailed list, view our report.

Key questions answered in this report:

What will the market size be in 2018 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this
market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1. Market Overview

03.2. Product Offerings

03.2.1. Product Profiles

04. Market Research Methodology

04.1. Market Research Process

04.2. Research Methodology

05. Introduction

06. Market Landscape

06.1. Market Overview

06.2. Market Size and Forecast

06.3. Five Forces Analysis

07. Rate of Incidence and Prevalence

08. Market Segmentation by Type of Therapy

08.1.1. Hormone Therapy

08.1.2. Analgesics

09. Market Segmentation by Route of Administration and Type of Dosage Form